Valuation: CellaVision AB

Market Cap 3.69B 387M 335M 315M 286M 538M 37.11B 546M 1.45B 18.56B 1.45B 1.42B 61.83B P/E 2026 *
26.5x
P/E 2027 * 21.2x
Enterprise Value 3.5B 368M 318M 299M 272M 511M 35.23B 518M 1.37B 17.62B 1.38B 1.35B 58.69B EV / Sales 2026 *
4.52x
EV / Sales 2027 * 3.99x
Free-Float
83.08%
Yield 2026 *
1.78%
Yield 2027 * 2.02%
1 day+1.29%
1 week+1.97%
Current month+5.57%
1 month+4.44%
3 months+25.12%
6 months+1.70%
Current year-1.15%
1 week 150.2
Extreme 150.2
156.8
1 month 138.4
Extreme 138.4
156.8
Current year 117.6
Extreme 117.6
166.8
1 year 117.6
Extreme 117.6
192.2
3 years 117.6
Extreme 117.6
302
5 years 117.6
Extreme 117.6
476.4
10 years 70.75
Extreme 70.75
503.5
Manager TitleAgeSince
Chief Executive Officer - 2026-06-04
Director of Finance/CFO 46 2025-09-01
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 61 -
Director/Board Member 62 2018-05-03
Chairman 64 2021-04-28
Date Insider Type Main position Quantity % Market Cap.
2/16/26 Buy 1,400 0.0059%
2/6/26 Buy

Founder

100,000 0.4193%
6/19/25 Sell

Founder

300 0.0013%
Change 5-day change 1-year change 3-year change Capi.($)
+1.29%+1.97%-5.01%-11.20% 387M
-0.72%-3.94%+15.08%-34.82% 16.5B
-2.03%-2.16%-27.05%+102.54% 1.72B
+0.19%-3.05%-25.53%+25.91% 966M
-7.89%-4.00%-47.99%-81.92% 921M
0.00%-0.65%+67.36%-7.38% 778M
-1.89%+0.35%-39.37%-48.32% 680M
-3.67%+2.99%-40.72%-39.57% 613M
-1.53%+4.73%-42.90%-37.12% 444M
-1.08%+0.70%+60.77%+43.79% 417M
Average -1.73%+1.19%-8.54%-8.81% 2.34B
Weighted average by Cap. -1.14%-2.59%+5.91%-21.95%

Financials

2026 *2027 *
Net sales 775M 81.31M 70.23M 66.08M 60.06M 113M 7.79B 115M 304M 3.9B 305M 299M 12.98B 870M 91.27M 78.83M 74.17M 67.41M 127M 8.74B 129M 341M 4.37B 343M 335M 14.57B
Net income 139M 14.58M 12.6M 11.85M 10.77M 20.26M 1.4B 20.56M 54.48M 699M 54.76M 53.57M 2.33B 174M 18.29M 15.8M 14.87M 13.51M 25.41M 1.75B 25.78M 68.34M 877M 68.68M 67.19M 2.92B
Net Debt -188M -19.67M -16.99M -15.98M -14.53M -27.33M -1.88B -27.73M -73.48M -943M -73.85M -72.25M -3.14B -222M -23.28M -20.11M -18.92M -17.19M -32.34M -2.23B -32.81M -86.96M -1.12B -87.4M -85.5M -3.72B
Logo CellaVision AB
CellaVision AB is a Sweden-based company active in the medical technology sector. The Company develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The Company operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.
Employees
251
Date Price Change Volume
26-08-19 SEK 155.40 +0.39% 2,805
26-08-18 SEK 154.80 +2.25% 12,565
26-08-17 SEK 151.40 -0.92% 19,445
26-08-14 SEK 152.80 +0.26% 15,825
26-08-13 SEK 152.40 0.00% 9,762
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
154.80SEK
Average target price
175.67SEK
Spread / Average Target
+13.48%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CEVI Stock